Global Mhealth Market
Global Mhealth Market

Mhealth Comprehensive Study by Type (Connected Devices, Apps, Services), Application (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Neurological Diseases, Others), End User (Physicians, Patients, Insurance Companies, Research Centers, Pharmacies, Biopharmaceutical Companies, Government, Tech Companies) Players and Region - Global Market Outlook to 2025

Mhealth Market Segmented into XX Submarkets. | Forecast Years: 2019- 2025 | CAGR: 25.4%  

Sep 2019 Edition 207 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Mhealth Market Overview:
mHealth being one of the eHealth aspects is getting advanced in acquiring, transporting, storing, processing and securing raw & processed data to deliver meaningful results. The rapid rise in the incidence of the chronic diseases as well as the advancing technologies in the mobile health apps has delivered information of personal healthcare on the regular basis which is one of the major factor fuelling the mHealth market. Mobile Health (mHealth) is a general term used for mobile health, which provides assistance to public health using smart devices such as; mobile phones, tablet computers & PDAs, and wearable devices such as smartwatches. It helps in educating consumers about preventive health care services. Some of the key players profiled in the study are Omron Corporation (United States), Apple, Inc. (United States), AirStrip Technologies (United States), AliveCor, Inc. (United States), BioTelemetry Inc. (United States), athenahealth, Inc. (United States), AgaMatrix, Inc. (United States), iHealth Lab, Inc. (United States), AT&T (United States), Cerner Corporation (United States), Cisco Systems, Inc. (United States), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), LifeWatch AG (Switzerland), Nokia Corporation (Finland) and Johnson & Johnson (United States). According to Market Analyst at AMA, the Global Mhealth market may see a growth rate of 25.4% and would reach the market size of USD151.48 Million by 2025.

On the basis of geography, the market of Mhealth has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. If we see Market by End User, the sub-segment i.e. Physicians will boost the Mhealth market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Use of Mobile phones, Tablets, Smart Phones and other Mobile Platform
  • Cost Containment of Healthcare Delivery
  • Rising Focus on Patient-Centric Healthcare Delivery
  • Increasing Consumption of Connected Devices and mHealth Apps for the Management of Chronic Diseases

Market Trend
  • Advancement in Technology of Connected Devices and mHealth App with Rise in use of Wearable Health Technology
  • Growing Application of Cloud-Based mHealth Solution
  • Remote monitoring and Growing Focus on Consumer- Centric Mobility Solutions

Restraints
  • Lack of Standards and Regulations
  • Increasing Concerns Regarding Health care Fraud And Data Theft which Require Data Security
  • Lack of guidance from Physicians while Selecting Apps

Opportunities
  • Rising Incidence of Lifestyle Disorders
  • Growing Adoption of mHealth Solutions

Challenges
  • Difficulties in Finding mHealth Apps in Stores
  • Patent Protection for mHealth Devices and Applications


In June 2017, Johnson & Johnson an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company acquired the Actelion

According to the United Nation Department of Economic and Social Affairs (UNDESA), world population ageing 2017 report, in North America, the population of people aged 60 years or above was approximately 78.4 million in 2017, and the number is estimated to reach 122.8 billion by 2050.

Target Audience:
Healthcare Application Developers, Medical Device Vendors, Mobile Network Providers, Connectivity Providers, Mobile Platform Developers, Insurance Providers (Payers), Healthcare Institutions (Hospitals, Medical Schools, And Outpatient Clinics), Research And Consulting Firms, Research Institutes, Contract Research Organizations (Cros), Contract Manufacturing Organizations (Cmos) and Venture Capitalists

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Mhealth market on the basis of product [Connected Devices, Apps and Services] , application [Cardiovascular Diseases, Diabetes, Respiratory Diseases, Neurological Diseases and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Mhealth market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Mhealth industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Diversinet Corporation (Canada) and Withings (France).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Mhealth market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Connected Devices
  • Apps
  • Services
By Application
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Neurological Diseases
  • Others
By End User
  • Physicians
  • Patients
  • Insurance Companies
  • Research Centers
  • Pharmacies
  • Biopharmaceutical Companies
  • Government
  • Tech Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Use of Mobile phones, Tablets, Smart Phones and other Mobile Platform
      • 3.2.2. Cost Containment of Healthcare Delivery
      • 3.2.3. Rising Focus on Patient-Centric Healthcare Delivery
      • 3.2.4. Increasing Consumption of Connected Devices and mHealth Apps for the Management of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Difficulties in Finding mHealth Apps in Stores
      • 3.3.2. Patent Protection for mHealth Devices and Applications
    • 3.4. Market Trends
      • 3.4.1. Advancement in Technology of Connected Devices and mHealth App with Rise in use of Wearable Health Technology
      • 3.4.2. Growing Application of Cloud-Based mHealth Solution
      • 3.4.3. Remote monitoring and Growing Focus on Consumer- Centric Mobility Solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Mhealth, by Type, Application, End User and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Mhealth (Value)
      • 5.2.1. Global Mhealth by: Type (Value)
        • 5.2.1.1. Connected Devices
        • 5.2.1.2. Apps
        • 5.2.1.3. Services
      • 5.2.2. Global Mhealth by: Application (Value)
        • 5.2.2.1. Cardiovascular Diseases
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Respiratory Diseases
        • 5.2.2.4. Neurological Diseases
        • 5.2.2.5. Others
      • 5.2.3. Global Mhealth by: End User (Value)
        • 5.2.3.1. Physicians
        • 5.2.3.2. Patients
        • 5.2.3.3. Insurance Companies
        • 5.2.3.4. Research Centers
        • 5.2.3.5. Pharmacies
        • 5.2.3.6. Biopharmaceutical Companies
        • 5.2.3.7. Government
        • 5.2.3.8. Tech Companies
      • 5.2.4. Global Mhealth Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Mhealth (Price)
      • 5.3.1. Global Mhealth by: Type (Price)
  • 6. Mhealth: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Omron Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Apple, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AirStrip Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AliveCor, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioTelemetry Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Athenahealth, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AgaMatrix, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IHealth Lab, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AT&T (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cerner Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cisco Systems, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Medtronic plc (Ireland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Koninklijke Philips N.V. (Netherlands)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. LifeWatch AG (Switzerland)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Nokia Corporation (Finland)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Johnson & Johnson (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Mhealth Sale, by Type, Application, End User and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Mhealth (Value)
      • 7.2.1. Global Mhealth by: Type (Value)
        • 7.2.1.1. Connected Devices
        • 7.2.1.2. Apps
        • 7.2.1.3. Services
      • 7.2.2. Global Mhealth by: Application (Value)
        • 7.2.2.1. Cardiovascular Diseases
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Respiratory Diseases
        • 7.2.2.4. Neurological Diseases
        • 7.2.2.5. Others
      • 7.2.3. Global Mhealth by: End User (Value)
        • 7.2.3.1. Physicians
        • 7.2.3.2. Patients
        • 7.2.3.3. Insurance Companies
        • 7.2.3.4. Research Centers
        • 7.2.3.5. Pharmacies
        • 7.2.3.6. Biopharmaceutical Companies
        • 7.2.3.7. Government
        • 7.2.3.8. Tech Companies
      • 7.2.4. Global Mhealth Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Mhealth (Price)
      • 7.3.1. Global Mhealth by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Mhealth: by Type(USD Million)
  • Table 2. Mhealth Connected Devices , by Region USD Million (2013-2018)
  • Table 3. Mhealth Apps , by Region USD Million (2013-2018)
  • Table 4. Mhealth Services , by Region USD Million (2013-2018)
  • Table 5. Mhealth: by Application(USD Million)
  • Table 6. Mhealth Cardiovascular Diseases , by Region USD Million (2013-2018)
  • Table 7. Mhealth Diabetes , by Region USD Million (2013-2018)
  • Table 8. Mhealth Respiratory Diseases , by Region USD Million (2013-2018)
  • Table 9. Mhealth Neurological Diseases , by Region USD Million (2013-2018)
  • Table 10. Mhealth Others , by Region USD Million (2013-2018)
  • Table 11. Mhealth: by End User(USD Million)
  • Table 12. Mhealth Physicians , by Region USD Million (2013-2018)
  • Table 13. Mhealth Patients , by Region USD Million (2013-2018)
  • Table 14. Mhealth Insurance Companies , by Region USD Million (2013-2018)
  • Table 15. Mhealth Research Centers , by Region USD Million (2013-2018)
  • Table 16. Mhealth Pharmacies , by Region USD Million (2013-2018)
  • Table 17. Mhealth Biopharmaceutical Companies , by Region USD Million (2013-2018)
  • Table 18. Mhealth Government , by Region USD Million (2013-2018)
  • Table 19. Mhealth Tech Companies , by Region USD Million (2013-2018)
  • Table 20. South America Mhealth, by Country USD Million (2013-2018)
  • Table 21. South America Mhealth, by Type USD Million (2013-2018)
  • Table 22. South America Mhealth, by Application USD Million (2013-2018)
  • Table 23. South America Mhealth, by End User USD Million (2013-2018)
  • Table 24. Brazil Mhealth, by Type USD Million (2013-2018)
  • Table 25. Brazil Mhealth, by Application USD Million (2013-2018)
  • Table 26. Brazil Mhealth, by End User USD Million (2013-2018)
  • Table 27. Argentina Mhealth, by Type USD Million (2013-2018)
  • Table 28. Argentina Mhealth, by Application USD Million (2013-2018)
  • Table 29. Argentina Mhealth, by End User USD Million (2013-2018)
  • Table 30. Rest of South America Mhealth, by Type USD Million (2013-2018)
  • Table 31. Rest of South America Mhealth, by Application USD Million (2013-2018)
  • Table 32. Rest of South America Mhealth, by End User USD Million (2013-2018)
  • Table 33. Asia Pacific Mhealth, by Country USD Million (2013-2018)
  • Table 34. Asia Pacific Mhealth, by Type USD Million (2013-2018)
  • Table 35. Asia Pacific Mhealth, by Application USD Million (2013-2018)
  • Table 36. Asia Pacific Mhealth, by End User USD Million (2013-2018)
  • Table 37. China Mhealth, by Type USD Million (2013-2018)
  • Table 38. China Mhealth, by Application USD Million (2013-2018)
  • Table 39. China Mhealth, by End User USD Million (2013-2018)
  • Table 40. Japan Mhealth, by Type USD Million (2013-2018)
  • Table 41. Japan Mhealth, by Application USD Million (2013-2018)
  • Table 42. Japan Mhealth, by End User USD Million (2013-2018)
  • Table 43. India Mhealth, by Type USD Million (2013-2018)
  • Table 44. India Mhealth, by Application USD Million (2013-2018)
  • Table 45. India Mhealth, by End User USD Million (2013-2018)
  • Table 46. South Korea Mhealth, by Type USD Million (2013-2018)
  • Table 47. South Korea Mhealth, by Application USD Million (2013-2018)
  • Table 48. South Korea Mhealth, by End User USD Million (2013-2018)
  • Table 49. Taiwan Mhealth, by Type USD Million (2013-2018)
  • Table 50. Taiwan Mhealth, by Application USD Million (2013-2018)
  • Table 51. Taiwan Mhealth, by End User USD Million (2013-2018)
  • Table 52. Australia Mhealth, by Type USD Million (2013-2018)
  • Table 53. Australia Mhealth, by Application USD Million (2013-2018)
  • Table 54. Australia Mhealth, by End User USD Million (2013-2018)
  • Table 55. Rest of Asia-Pacific Mhealth, by Type USD Million (2013-2018)
  • Table 56. Rest of Asia-Pacific Mhealth, by Application USD Million (2013-2018)
  • Table 57. Rest of Asia-Pacific Mhealth, by End User USD Million (2013-2018)
  • Table 58. Europe Mhealth, by Country USD Million (2013-2018)
  • Table 59. Europe Mhealth, by Type USD Million (2013-2018)
  • Table 60. Europe Mhealth, by Application USD Million (2013-2018)
  • Table 61. Europe Mhealth, by End User USD Million (2013-2018)
  • Table 62. Germany Mhealth, by Type USD Million (2013-2018)
  • Table 63. Germany Mhealth, by Application USD Million (2013-2018)
  • Table 64. Germany Mhealth, by End User USD Million (2013-2018)
  • Table 65. France Mhealth, by Type USD Million (2013-2018)
  • Table 66. France Mhealth, by Application USD Million (2013-2018)
  • Table 67. France Mhealth, by End User USD Million (2013-2018)
  • Table 68. Italy Mhealth, by Type USD Million (2013-2018)
  • Table 69. Italy Mhealth, by Application USD Million (2013-2018)
  • Table 70. Italy Mhealth, by End User USD Million (2013-2018)
  • Table 71. United Kingdom Mhealth, by Type USD Million (2013-2018)
  • Table 72. United Kingdom Mhealth, by Application USD Million (2013-2018)
  • Table 73. United Kingdom Mhealth, by End User USD Million (2013-2018)
  • Table 74. Netherlands Mhealth, by Type USD Million (2013-2018)
  • Table 75. Netherlands Mhealth, by Application USD Million (2013-2018)
  • Table 76. Netherlands Mhealth, by End User USD Million (2013-2018)
  • Table 77. Rest of Europe Mhealth, by Type USD Million (2013-2018)
  • Table 78. Rest of Europe Mhealth, by Application USD Million (2013-2018)
  • Table 79. Rest of Europe Mhealth, by End User USD Million (2013-2018)
  • Table 80. MEA Mhealth, by Country USD Million (2013-2018)
  • Table 81. MEA Mhealth, by Type USD Million (2013-2018)
  • Table 82. MEA Mhealth, by Application USD Million (2013-2018)
  • Table 83. MEA Mhealth, by End User USD Million (2013-2018)
  • Table 84. Middle East Mhealth, by Type USD Million (2013-2018)
  • Table 85. Middle East Mhealth, by Application USD Million (2013-2018)
  • Table 86. Middle East Mhealth, by End User USD Million (2013-2018)
  • Table 87. Africa Mhealth, by Type USD Million (2013-2018)
  • Table 88. Africa Mhealth, by Application USD Million (2013-2018)
  • Table 89. Africa Mhealth, by End User USD Million (2013-2018)
  • Table 90. North America Mhealth, by Country USD Million (2013-2018)
  • Table 91. North America Mhealth, by Type USD Million (2013-2018)
  • Table 92. North America Mhealth, by Application USD Million (2013-2018)
  • Table 93. North America Mhealth, by End User USD Million (2013-2018)
  • Table 94. United States Mhealth, by Type USD Million (2013-2018)
  • Table 95. United States Mhealth, by Application USD Million (2013-2018)
  • Table 96. United States Mhealth, by End User USD Million (2013-2018)
  • Table 97. Canada Mhealth, by Type USD Million (2013-2018)
  • Table 98. Canada Mhealth, by Application USD Million (2013-2018)
  • Table 99. Canada Mhealth, by End User USD Million (2013-2018)
  • Table 100. Mexico Mhealth, by Type USD Million (2013-2018)
  • Table 101. Mexico Mhealth, by Application USD Million (2013-2018)
  • Table 102. Mexico Mhealth, by End User USD Million (2013-2018)
  • Table 103. Mhealth: by Type(USD/Units)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Mhealth: by Type(USD Million)
  • Table 121. Mhealth Connected Devices , by Region USD Million (2020-2025)
  • Table 122. Mhealth Apps , by Region USD Million (2020-2025)
  • Table 123. Mhealth Services , by Region USD Million (2020-2025)
  • Table 124. Mhealth: by Application(USD Million)
  • Table 125. Mhealth Cardiovascular Diseases , by Region USD Million (2020-2025)
  • Table 126. Mhealth Diabetes , by Region USD Million (2020-2025)
  • Table 127. Mhealth Respiratory Diseases , by Region USD Million (2020-2025)
  • Table 128. Mhealth Neurological Diseases , by Region USD Million (2020-2025)
  • Table 129. Mhealth Others , by Region USD Million (2020-2025)
  • Table 130. Mhealth: by End User(USD Million)
  • Table 131. Mhealth Physicians , by Region USD Million (2020-2025)
  • Table 132. Mhealth Patients , by Region USD Million (2020-2025)
  • Table 133. Mhealth Insurance Companies , by Region USD Million (2020-2025)
  • Table 134. Mhealth Research Centers , by Region USD Million (2020-2025)
  • Table 135. Mhealth Pharmacies , by Region USD Million (2020-2025)
  • Table 136. Mhealth Biopharmaceutical Companies , by Region USD Million (2020-2025)
  • Table 137. Mhealth Government , by Region USD Million (2020-2025)
  • Table 138. Mhealth Tech Companies , by Region USD Million (2020-2025)
  • Table 139. South America Mhealth, by Country USD Million (2020-2025)
  • Table 140. South America Mhealth, by Type USD Million (2020-2025)
  • Table 141. South America Mhealth, by Application USD Million (2020-2025)
  • Table 142. South America Mhealth, by End User USD Million (2020-2025)
  • Table 143. Brazil Mhealth, by Type USD Million (2020-2025)
  • Table 144. Brazil Mhealth, by Application USD Million (2020-2025)
  • Table 145. Brazil Mhealth, by End User USD Million (2020-2025)
  • Table 146. Argentina Mhealth, by Type USD Million (2020-2025)
  • Table 147. Argentina Mhealth, by Application USD Million (2020-2025)
  • Table 148. Argentina Mhealth, by End User USD Million (2020-2025)
  • Table 149. Rest of South America Mhealth, by Type USD Million (2020-2025)
  • Table 150. Rest of South America Mhealth, by Application USD Million (2020-2025)
  • Table 151. Rest of South America Mhealth, by End User USD Million (2020-2025)
  • Table 152. Asia Pacific Mhealth, by Country USD Million (2020-2025)
  • Table 153. Asia Pacific Mhealth, by Type USD Million (2020-2025)
  • Table 154. Asia Pacific Mhealth, by Application USD Million (2020-2025)
  • Table 155. Asia Pacific Mhealth, by End User USD Million (2020-2025)
  • Table 156. China Mhealth, by Type USD Million (2020-2025)
  • Table 157. China Mhealth, by Application USD Million (2020-2025)
  • Table 158. China Mhealth, by End User USD Million (2020-2025)
  • Table 159. Japan Mhealth, by Type USD Million (2020-2025)
  • Table 160. Japan Mhealth, by Application USD Million (2020-2025)
  • Table 161. Japan Mhealth, by End User USD Million (2020-2025)
  • Table 162. India Mhealth, by Type USD Million (2020-2025)
  • Table 163. India Mhealth, by Application USD Million (2020-2025)
  • Table 164. India Mhealth, by End User USD Million (2020-2025)
  • Table 165. South Korea Mhealth, by Type USD Million (2020-2025)
  • Table 166. South Korea Mhealth, by Application USD Million (2020-2025)
  • Table 167. South Korea Mhealth, by End User USD Million (2020-2025)
  • Table 168. Taiwan Mhealth, by Type USD Million (2020-2025)
  • Table 169. Taiwan Mhealth, by Application USD Million (2020-2025)
  • Table 170. Taiwan Mhealth, by End User USD Million (2020-2025)
  • Table 171. Australia Mhealth, by Type USD Million (2020-2025)
  • Table 172. Australia Mhealth, by Application USD Million (2020-2025)
  • Table 173. Australia Mhealth, by End User USD Million (2020-2025)
  • Table 174. Rest of Asia-Pacific Mhealth, by Type USD Million (2020-2025)
  • Table 175. Rest of Asia-Pacific Mhealth, by Application USD Million (2020-2025)
  • Table 176. Rest of Asia-Pacific Mhealth, by End User USD Million (2020-2025)
  • Table 177. Europe Mhealth, by Country USD Million (2020-2025)
  • Table 178. Europe Mhealth, by Type USD Million (2020-2025)
  • Table 179. Europe Mhealth, by Application USD Million (2020-2025)
  • Table 180. Europe Mhealth, by End User USD Million (2020-2025)
  • Table 181. Germany Mhealth, by Type USD Million (2020-2025)
  • Table 182. Germany Mhealth, by Application USD Million (2020-2025)
  • Table 183. Germany Mhealth, by End User USD Million (2020-2025)
  • Table 184. France Mhealth, by Type USD Million (2020-2025)
  • Table 185. France Mhealth, by Application USD Million (2020-2025)
  • Table 186. France Mhealth, by End User USD Million (2020-2025)
  • Table 187. Italy Mhealth, by Type USD Million (2020-2025)
  • Table 188. Italy Mhealth, by Application USD Million (2020-2025)
  • Table 189. Italy Mhealth, by End User USD Million (2020-2025)
  • Table 190. United Kingdom Mhealth, by Type USD Million (2020-2025)
  • Table 191. United Kingdom Mhealth, by Application USD Million (2020-2025)
  • Table 192. United Kingdom Mhealth, by End User USD Million (2020-2025)
  • Table 193. Netherlands Mhealth, by Type USD Million (2020-2025)
  • Table 194. Netherlands Mhealth, by Application USD Million (2020-2025)
  • Table 195. Netherlands Mhealth, by End User USD Million (2020-2025)
  • Table 196. Rest of Europe Mhealth, by Type USD Million (2020-2025)
  • Table 197. Rest of Europe Mhealth, by Application USD Million (2020-2025)
  • Table 198. Rest of Europe Mhealth, by End User USD Million (2020-2025)
  • Table 199. MEA Mhealth, by Country USD Million (2020-2025)
  • Table 200. MEA Mhealth, by Type USD Million (2020-2025)
  • Table 201. MEA Mhealth, by Application USD Million (2020-2025)
  • Table 202. MEA Mhealth, by End User USD Million (2020-2025)
  • Table 203. Middle East Mhealth, by Type USD Million (2020-2025)
  • Table 204. Middle East Mhealth, by Application USD Million (2020-2025)
  • Table 205. Middle East Mhealth, by End User USD Million (2020-2025)
  • Table 206. Africa Mhealth, by Type USD Million (2020-2025)
  • Table 207. Africa Mhealth, by Application USD Million (2020-2025)
  • Table 208. Africa Mhealth, by End User USD Million (2020-2025)
  • Table 209. North America Mhealth, by Country USD Million (2020-2025)
  • Table 210. North America Mhealth, by Type USD Million (2020-2025)
  • Table 211. North America Mhealth, by Application USD Million (2020-2025)
  • Table 212. North America Mhealth, by End User USD Million (2020-2025)
  • Table 213. United States Mhealth, by Type USD Million (2020-2025)
  • Table 214. United States Mhealth, by Application USD Million (2020-2025)
  • Table 215. United States Mhealth, by End User USD Million (2020-2025)
  • Table 216. Canada Mhealth, by Type USD Million (2020-2025)
  • Table 217. Canada Mhealth, by Application USD Million (2020-2025)
  • Table 218. Canada Mhealth, by End User USD Million (2020-2025)
  • Table 219. Mexico Mhealth, by Type USD Million (2020-2025)
  • Table 220. Mexico Mhealth, by Application USD Million (2020-2025)
  • Table 221. Mexico Mhealth, by End User USD Million (2020-2025)
  • Table 222. Mhealth: by Type(USD/Units)
  • Table 223. Research Programs/Design for This Report
  • Table 224. Key Data Information from Secondary Sources
  • Table 225. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Mhealth: by Type USD Million (2013-2018)
  • Figure 5. Global Mhealth: by Application USD Million (2013-2018)
  • Figure 6. Global Mhealth: by End User USD Million (2013-2018)
  • Figure 7. South America Mhealth Share (%), by Country
  • Figure 8. Asia Pacific Mhealth Share (%), by Country
  • Figure 9. Europe Mhealth Share (%), by Country
  • Figure 10. MEA Mhealth Share (%), by Country
  • Figure 11. North America Mhealth Share (%), by Country
  • Figure 12. Global Mhealth: by Type USD/Units (2013-2018)
  • Figure 13. Global Mhealth share by Players 2018 (%)
  • Figure 14. Global Mhealth share by Players (Top 3) 2018(%)
  • Figure 15. Global Mhealth share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Omron Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Omron Corporation (United States) Revenue: by Geography 2018
  • Figure 19. Apple, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Apple, Inc. (United States) Revenue: by Geography 2018
  • Figure 21. AirStrip Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 22. AirStrip Technologies (United States) Revenue: by Geography 2018
  • Figure 23. AliveCor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. AliveCor, Inc. (United States) Revenue: by Geography 2018
  • Figure 25. BioTelemetry Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. BioTelemetry Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Athenahealth, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Athenahealth, Inc. (United States) Revenue: by Geography 2018
  • Figure 29. AgaMatrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. AgaMatrix, Inc. (United States) Revenue: by Geography 2018
  • Figure 31. IHealth Lab, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. IHealth Lab, Inc. (United States) Revenue: by Geography 2018
  • Figure 33. AT&T (United States) Revenue, Net Income and Gross profit
  • Figure 34. AT&T (United States) Revenue: by Geography 2018
  • Figure 35. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Cerner Corporation (United States) Revenue: by Geography 2018
  • Figure 37. Cisco Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cisco Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 39. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 40. Medtronic plc (Ireland) Revenue: by Geography 2018
  • Figure 41. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 42. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2018
  • Figure 43. LifeWatch AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. LifeWatch AG (Switzerland) Revenue: by Geography 2018
  • Figure 45. Nokia Corporation (Finland) Revenue, Net Income and Gross profit
  • Figure 46. Nokia Corporation (Finland) Revenue: by Geography 2018
  • Figure 47. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 48. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 49. Global Mhealth: by Type USD Million (2020-2025)
  • Figure 50. Global Mhealth: by Application USD Million (2020-2025)
  • Figure 51. Global Mhealth: by End User USD Million (2020-2025)
  • Figure 52. South America Mhealth Share (%), by Country
  • Figure 53. Asia Pacific Mhealth Share (%), by Country
  • Figure 54. Europe Mhealth Share (%), by Country
  • Figure 55. MEA Mhealth Share (%), by Country
  • Figure 56. North America Mhealth Share (%), by Country
  • Figure 57. Global Mhealth: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Omron Corporation (United States)
  • Apple, Inc. (United States)
  • AirStrip Technologies (United States)
  • AliveCor, Inc. (United States)
  • BioTelemetry Inc. (United States)
  • athenahealth, Inc. (United States)
  • AgaMatrix, Inc. (United States)
  • iHealth Lab, Inc. (United States)
  • AT&T (United States)
  • Cerner Corporation (United States)
  • Cisco Systems, Inc. (United States)
  • Medtronic plc (Ireland)
  • Koninklijke Philips N.V. (Netherlands)
  • LifeWatch AG (Switzerland)
  • Nokia Corporation (Finland)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Diversinet Corporation (Canada) , Withings (France)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation